Since its inception in 1995, PharmaSeek has partnered with Sponsors and CROs to identify investigative sites for clinical trials. What initially began as a group of twelve Midwestern sites has blossomed into a network of 250 sites located throughout the United States, Canada, Mexico, and the Caribbean. Included in our network are research facilities, multi-specialty practices, and academic institutions. As a group, PharmaSeek sites practice research in virtually every therapeutic area.

Our goal is to connect quality clinical studies with experienced, high performing research sites. PharmaSeek expedites the study start-up phase by streamlining the site selection process and critical document control. This includes supplying a list of pre-qualified sites and assisting with study administration and start-up, including budgeting, contracting and regulatory submissions. Once the site is initiated, we assist with patient recruitment and track timely, accurate payment for services provided by our investigative sites.

PharmaSeek operates as an Investigative Site Network (ISN). Unlike a Site Management Organization (SMO), we do not maintain an equity ownership in our sites nor do our sites have ownership in PharmaSeek. Our success is based upon our ability to add value to our sites’ clinical research activities.